• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短程和长程激素疗法治疗儿童肾病综合征的复发率比较。

Outcome Of Short And Long Duration Steroid Therapy In Childhood Nephrotic Syndrome In Terms Of Frequency Of Relapse Rate.

机构信息

Children's Hospital, Lahore, Pakistan.

Children's Hospital, Lahore-Pakistan.

出版信息

J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):300-303. doi: 10.55519/JAMC-02-9324.

DOI:10.55519/JAMC-02-9324
PMID:35576290
Abstract

BACKGROUND

Nephrotic syndrome is a clinical syndrome defined by massive proteinuria (greater than 40 mg/m2/hour) responsible for hypoalbuminemia (less than 30 g/L) resulting in oedema and hyperlipidaemia. Objective of the study was to compare the frequency of relapse rate with short and long duration steroid therapy in Nephrotic syndrome. It was a Quasiexperimental control group design, conducted at the Department of Paediatric Nephrology, The Children's Hospital and Institute of Child Health, Lahore. Duration of study: One year.

METHODS

The data of 150 patients with steroid sensitive nephrotic syndrome was included with clinical presentation and diagnostic investigations. The children were randomly divided into long and short duration steroid treatment groups. Outcome was determined in terms of relapse rate after achieving remission with both treatment strategies. Independent sample t test was applied to compare the outcome in both groups with p≤0.05 considered as significant. Data was stratified for all the effect modifiers like age and gender and poststratification chi square test was applied to see the effect on the outcome, taking p≤0.05 as significant.

RESULTS

The relapse rate of the disease was 0.8±0.72 per year in short-duration group and 1.28±0.61 per year in subjects receiving long-duration steroids, and difference between the two groups was found to be statistically significant (p<0.001). The relapse rate was less in the short duration therapy group as compared to the long duration therapy 62.7% (n=47) patients in group A had one or more relapses of the disease within one year of follow up in contrast to 94.7% (n=71) children in group B (p<0.001).

CONCLUSIONS

Patients receiving short duration steroid therapy showed a lower relapse rate as compared to those who were administered long term steroids.

摘要

背景

肾病综合征是一种临床综合征,其特征为大量蛋白尿(>40mg/m2/h),导致低白蛋白血症(<30g/L),进而引起水肿和高脂血症。本研究旨在比较短期和长期类固醇治疗肾病综合征的复发率。这是一项准实验对照组设计,在拉合尔儿童医院和儿童健康研究所儿科肾病科进行。研究持续时间为一年。

方法

纳入了 150 名符合类固醇敏感肾病综合征临床表现和诊断标准的患者。这些儿童被随机分为短期和长期类固醇治疗组。两种治疗策略均达到缓解后,根据复发率来确定结局。采用独立样本 t 检验比较两组的结局,p≤0.05 为差异有统计学意义。对所有效应修饰因子(如年龄和性别)进行分层,并应用事后卡方检验来观察其对结局的影响,p≤0.05 为差异有统计学意义。

结果

短期组的疾病复发率为 0.8±0.72/年,长期组为 1.28±0.61/年,两组之间的差异具有统计学意义(p<0.001)。与长期组相比,短期组的复发率较低,在随访的一年内,A 组 62.7%(n=47)的患者出现一次或多次疾病复发,而 B 组 94.7%(n=71)的儿童(p<0.001)。

结论

与长期接受类固醇治疗的患者相比,接受短期类固醇治疗的患者复发率较低。

相似文献

1
Outcome Of Short And Long Duration Steroid Therapy In Childhood Nephrotic Syndrome In Terms Of Frequency Of Relapse Rate.短程和长程激素疗法治疗儿童肾病综合征的复发率比较。
J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):300-303. doi: 10.55519/JAMC-02-9324.
2
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.十六周与标准八周泼尼松治疗儿童肾病综合征的随机对照试验:PREDNOS RCT。
Health Technol Assess. 2019 May;23(26):1-108. doi: 10.3310/hta23260.
3
Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.短程泼尼松龙治疗肾病综合征复发患儿的非劣效性随机对照试验。
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):225-232. doi: 10.2215/CJN.06140420. Epub 2021 Jan 21.
4
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.每日低剂量泼尼松预防上呼吸道感染儿童中类固醇敏感型肾病综合征复发:PREDNOS2 RCT。
Health Technol Assess. 2022 Jan;26(3):1-94. doi: 10.3310/WTFC5658.
5
Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.泼尼松低剂量治疗激素敏感型肾病综合征复发:一项前瞻性随机初步研究。
Eur J Pediatr. 2020 Feb;179(2):279-283. doi: 10.1007/s00431-019-03506-5. Epub 2019 Nov 14.
6
Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.利妥昔单抗治疗儿童难治性肾病综合征:一项多中心回顾性研究。
Turk J Med Sci. 2021 Aug 30;51(4):1781-1790. doi: 10.3906/sag-2012-297.
7
[Clinical presentation and prognosis in children over 10-year-old with primary nephrotic syndrome].[10岁以上儿童原发性肾病综合征的临床表现及预后]
Zhonghua Er Ke Za Zhi. 2023 Aug 2;61(8):708-713. doi: 10.3760/cma.j.cn112140-20230104-00007.
8
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.国际儿科肾病学会关于儿童激素敏感性肾病综合征诊断和治疗的临床实践建议。
Pediatr Nephrol. 2023 Mar;38(3):877-919. doi: 10.1007/s00467-022-05739-3. Epub 2022 Oct 21.
9
Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.在上呼吸道感染期间每日服用泼尼松龙的短期疗程可降低儿童肾病综合征的复发频率。
Pediatr Nephrol. 2017 Aug;32(8):1377-1382. doi: 10.1007/s00467-017-3640-5. Epub 2017 Mar 24.
10
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).研究方案:吗替麦考酚酯作为利妥昔单抗治疗儿童起病、复杂、频繁复发型肾病综合征或激素依赖型肾病综合征后的维持治疗:一项多中心、双盲、随机、安慰剂对照试验(JSKDC07)。
BMC Nephrol. 2018 Nov 1;19(1):302. doi: 10.1186/s12882-018-1099-7.

引用本文的文献

1
Steroid-sensitive nephrotic syndrome in children: Korean Society of Pediatric Nephrology clinical practice recommendations.儿童类固醇敏感性肾病综合征:韩国小儿肾脏病学会临床实践建议
Kidney Res Clin Pract. 2025 Jul;44(4):553-565. doi: 10.23876/j.krcp.25.130. Epub 2025 Jun 27.
2
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗。
Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD001533. doi: 10.1002/14651858.CD001533.pub7.